{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:38:47Z","timestamp":1712795927643},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,9]]},"DOI":"10.7759\/cureus.57939","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T05:12:20Z","timestamp":1712725940000},"source":"Crossref","is-referenced-by-count":0,"title":["A Systematic Analysis of COVID-19 Clinical Trials Registered in the Clinical Trials Registry of India"],"prefix":"10.7759","author":[{"given":"Siddhartha","family":"Dutta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubha","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rima","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"National Institutes of Health (NIH). NIH's definition of a clinical trial. (2017). Accessed. March 18, 2024: https:\/\/grants.nih.gov\/policy\/clinical-trials\/definition.htm."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju229","article-title":"Adult cancer clinical trials that fail to complete: an epidemic?","volume":"106","author":"Stensland KD","year":"2014","unstructured":"Stensland KD, McBride RB, Latif A, et al.. Adult cancer clinical trials that fail to complete: an epidemic?. J Natl Cancer Inst. 2014, 106:dju229. 10.1093\/jnci\/dju229","journal-title":"J Natl Cancer Inst"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127242","article-title":"Terminated trials in the ClinicalTrials.gov results database: evaluation of availability of primary outcome data and reasons for termination","volume":"10","author":"Williams RJ","year":"2015","unstructured":"Williams RJ, Tse T, DiPiazza K, Zarin DA. Terminated trials in the ClinicalTrials.gov results database: evaluation of availability of primary outcome data and reasons for termination. PLoS One. 2015, 10:e0127242. 10.1371\/journal.pone.0127242","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/OAJCT.S285177","article-title":"Terminated interventional trials in the Clinical Trial Registry of India database: an analysis to evaluate the reasons for termination","volume":"12","author":"Dutta S","year":"2020","unstructured":"Dutta S, Kaur R, Haque M, et al.. Terminated interventional trials in the Clinical Trial Registry of India database: an analysis to evaluate the reasons for termination. Open Access J Clin Trials. 2020, 12:61-70. 10.2147\/OAJCT.S285177","journal-title":"Open Access J Clin Trials"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-020-00931-4","article-title":"Use of complementary and alternative medicine (CAM) and home remedies by COVID-19 patients: a telephonic survey","volume":"36","author":"Charan J","year":"2021","unstructured":"Charan J, Bhardwaj P, Dutta S, et al.. Use of complementary and alternative medicine (CAM) and home remedies by COVID-19 patients: a telephonic survey. Indian J Clin Biochem. 2021, 36:108-11. 10.1007\/s12291-020-00931-4","journal-title":"Indian J Clin Biochem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2021.1946513","article-title":"Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database","volume":"20","author":"Charan J","year":"2021","unstructured":"Charan J, Dutta S, Kaur R, et al.. Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database. Expert Opin Drug Saf. 2021, 20:1125-36. 10.1080\/14740338.2021.1946513","journal-title":"Expert Opin Drug Saf"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S307333","article-title":"Fat-soluble vitamins and the current global pandemic of COVID-19: evidence-based efficacy from literature review","volume":"14","author":"Samad N","year":"2021","unstructured":"Samad N, Dutta S, Sodunke TE, et al.. Fat-soluble vitamins and the current global pandemic of COVID-19: evidence-based efficacy from literature review. J Inflamm Res. 2021, 14:2091-110. 10.2147\/JIR.S307333","journal-title":"J Inflamm Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S295377","article-title":"The implications of zinc therapy in combating the COVID-19 global pandemic","volume":"14","author":"Samad N","year":"2021","unstructured":"Samad N, Sodunke TE, Abubakar AR, et al.. The implications of zinc therapy in combating the COVID-19 global pandemic. J Inflamm Res. 2021, 14:527-50. 10.2147\/JIR.S295377","journal-title":"J Inflamm Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21376","article-title":"Analysis of neurological adverse events reported in VigiBase from COVID-19 vaccines","volume":"14","author":"Dutta S","year":"2022","unstructured":"Dutta S, Kaur R, Charan J, et al.. Analysis of neurological adverse events reported in VigiBase from COVID-19 vaccines. Cureus. 2022, 14:e21376. 10.7759\/cureus.21376","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S324349","article-title":"Cardiovascular adverse events reported from COVID-19 vaccines: a study based on WHO database","volume":"14","author":"Jeet Kaur R","year":"2021","unstructured":"Jeet Kaur R, Dutta S, Charan J, et al.. Cardiovascular adverse events reported from COVID-19 vaccines: a study based on WHO database. Int J Gen Med. 2021, 14:3909-27. 10.2147\/IJGM.S324349","journal-title":"Int J Gen Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-021-00968-z","article-title":"Adverse events reported from COVID-19 vaccine trials: a systematic review","volume":"36","author":"Kaur RJ","year":"2021","unstructured":"Kaur RJ, Dutta S, Bhardwaj P, et al.. Adverse events reported from COVID-19 vaccine trials: a systematic review. Indian J Clin Biochem. 2021, 36:427-39. 10.1007\/s12291-021-00968-z","journal-title":"Indian J Clin Biochem"},{"key":"ref12","unstructured":"ICMR's National Institute of Medical Statistics. Clinical Trials Registry - India. (2024). Accessed. March 18, 2024: https:\/\/ctri.nic.in\/Clinicaltrials\/login.php."},{"key":"ref13","unstructured":"ICMR's National Institute of Medical Statistics. About Clinical Trials Registry - India. (2024). Accessed. March 18, 2024: https:\/\/ctri.nic.in\/Clinicaltrials\/cont1.php."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaim.2020.10.012","article-title":"A critical analysis of CTRI registered AYUSH studies for COVID-19","volume":"13","author":"Bhapkar V","year":"2022","unstructured":"Bhapkar V, Sawant T, Bhalerao S. A critical analysis of CTRI registered AYUSH studies for COVID-19. J Ayurveda Integr Med. 2022, 13:100370. 10.1016\/j.jaim.2020.10.012","journal-title":"J Ayurveda Integr Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.13005\/bpj\/2096","article-title":"Description and analysis of characteristics of COVID-19 clinical trials registered in the Clinical Trials Registry-India (CTRI)","volume":"14","author":"Abinaya E","year":"2021","unstructured":"Abinaya E, Saradha S, Ilamathi KR, Ruckmani A, Arunkumar R. Description and analysis of characteristics of COVID-19 clinical trials registered in the Clinical Trials Registry-India (CTRI). Biomed Pharmacol J. 2021, 14:10.13005\/bpj\/2096","journal-title":"Biomed Pharmacol J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-020-00918-1","article-title":"Snapshot of COVID-19 related clinical trials in India","volume":"35","author":"Charan J","year":"2020","unstructured":"Charan J, Kaur R, Bhardwaj P, et al.. Snapshot of COVID-19 related clinical trials in India. Indian J Clin Biochem. 2020, 35:418-22. 10.1007\/s12291-020-00918-1","journal-title":"Indian J Clin Biochem"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.14.20212761","article-title":"Characteristics of COVID-19 clinical trials in India based on the registration data on CTRI (Clinical Trials Registry- India): a cross-sectional analysis. [PREPRINT]","author":"Sathiyarajeswaran P","year":"2020","unstructured":"Sathiyarajeswaran P, Devi MS, Kanakavalli K, Vinod NP. Characteristics of COVID-19 clinical trials in India based on the registration data on CTRI (Clinical Trials Registry- India): a cross-sectional analysis. [PREPRINT]. medRxiv. 2020, 10.1101\/2020.10.14.20212761","journal-title":"medRxiv"},{"key":"ref18","article-title":"Evaluation of COVID-19 studies registered with the Clinical Trials Registry of India [CTRI] - a database analysis","volume":"69","author":"Chaudhari VL","year":"2021","unstructured":"Chaudhari VL, Godbole CJ, Bendkhale SR, Desai NN, Gogtay NJ, Thatte UM. Evaluation of COVID-19 studies registered with the Clinical Trials Registry of India [CTRI] - a database analysis. J Assoc Physicians India. 2021, 69:11-2.","journal-title":"J Assoc Physicians India"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.25259\/IJPP_238_2020","article-title":"Characterisation of current pharmacotherapeutic COVID-19 clinical trials in India: A registry-based descriptive analysis","volume":"65","author":"Bandyopadhyay A","year":"2021","unstructured":"Bandyopadhyay A, Choudhary C, Agnihotri A, Handu S. Characterisation of current pharmacotherapeutic COVID-19 clinical trials in India: A registry-based descriptive analysis. Indian J Physiol Pharmacol. 2021, 65:141-5. 10.25259\/IJPP_238_2020","journal-title":"Indian J Physiol Pharmacol"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.3674093","article-title":"Indian clinical trials on COVID-19: a review of Clinical Trials Registry of India (CTRI). [PREPRINT]","author":"Vasantha Raju N","year":"2020","unstructured":"Vasantha Raju N, Harinarayana NS. Indian clinical trials on COVID-19: a review of Clinical Trials Registry of India (CTRI). [PREPRINT]. SSRN. 2020, 3674093.","journal-title":"SSRN"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_2556_20","article-title":"Emerging trends from COVID-19 research registered in the Clinical Trials Registry - India","volume":"153","author":"Rao MV","year":"2021","unstructured":"Rao MV, Juneja A, Maulik M, et al.. Emerging trends from COVID-19 research registered in the Clinical Trials Registry - India. Indian J Med Res. 2021, 153:26-63. 10.4103\/ijmr.IJMR_2556_20","journal-title":"Indian J Med Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.5455\/njppp.2022.12.08408202206092022","article-title":"Analysis of COVID-19-related clinical trials registered in the Clinical Trial Registry of India in 2020: a descriptive study","volume":"12","author":"Bhave K","year":"2022","unstructured":"Bhave K, Thiyam A, Patel T, Chavan M, Desai S. Analysis of COVID-19-related clinical trials registered in the Clinical Trial Registry of India in 2020: a descriptive study. Natl J Physiol Pharm Pharmacol. 2022, 12:1669-74. 10.5455\/njppp.2022.12.08408202206092022","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"ref23","unstructured":"Ministry of AYUSH, Government of India. Constitution of an \"Interdisciplinary AYUSH research and development Task Force\" in the Ministry of AYUSH for initiating, coordinating and monitoring the R & D activities in the AYUSH sector related to SARS-Cov-2 virus and the COVID-19 disease. (2020). Accessed. March 15, 2024: https:\/\/www.icssr.org\/sites\/default\/files\/Notification%20on%20task%20force002.pdf."},{"key":"ref24","unstructured":"Scientific research in Ayush for COVID-19 treatment. (2021). Accessed. March 15, 2024: https:\/\/www.pib.gov.in\/Pressreleaseshare.aspx?PRID=1706948."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaim.2022.100631","article-title":"A methodological analysis of CTRI registered clinical trials on Ayurveda interventions for COVID-19 management","volume":"14","author":"Chaudhari SS","year":"2023","unstructured":"Chaudhari SS, Somvanshi PR. A methodological analysis of CTRI registered clinical trials on Ayurveda interventions for COVID-19 management. J Ayurveda Integr Med. 2023, 14:100631. 10.1016\/j.jaim.2022.100631","journal-title":"J Ayurveda Integr Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s40199-021-00422-8","article-title":"Characteristics of published\/registered clinical trials on COVID-19 treatment: a systematic review","volume":"29","author":"Asili P","year":"2021","unstructured":"Asili P, Mirahmad M, Tabatabaei-Malazy O, Manayi A, Haghighat E, Mahdavi M, Larijani B. Characteristics of published\/registered clinical trials on COVID-19 treatment: a systematic review. Daru. 2021, 29:449-67. 10.1007\/s40199-021-00422-8","journal-title":"Daru"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/jamiaopen\/ooab032","article-title":"How the clinical research community responded to the COVID-19 pandemic: an analysis of the COVID-19 clinical studies in ClinicalTrials.gov","volume":"4","author":"He Z","year":"2021","unstructured":"He Z, Erdengasileng A, Luo X, Xing A, Charness N, Bian J. How the clinical research community responded to the COVID-19 pandemic: an analysis of the COVID-19 clinical studies in ClinicalTrials.gov. JAMIA Open. 2021, 4:ooab032. 10.1093\/jamiaopen\/ooab032","journal-title":"JAMIA Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/242476-a-systematic-analysis-of-covid-19-clinical-trials-registered-in-the-clinical-trials-registry-of-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T05:12:39Z","timestamp":1712725959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/242476-a-systematic-analysis-of-covid-19-clinical-trials-registered-in-the-clinical-trials-registry-of-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,9]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.57939","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,9]]}}}